Provided by Tiger Fintech (Singapore) Pte. Ltd.

Myers

15.53
-0.1000-0.64%
Post-market: 15.530.00000.00%16:23 EDT
Volume:92.70K
Turnover:1.44M
Market Cap:580.55M
PE:55.43
High:15.77
Open:15.61
Low:15.35
Close:15.63
Loading ...

With A 5.6% Return On Equity, Is Myers Industries, Inc. (NYSE:MYE) A Quality Stock?

Simply Wall St.
·
14 Feb

Bristol Myers Squibb Cancer Treatment Misses Primary Endpoint in Trial

Dow Jones
·
14 Feb

Bristol Myers’ Phase 3 RELATIVITY-098 for Opdualag did not meet primary endpoint

TIPRANKS
·
14 Feb

Derek Myers Acquires Significant Stake in eEnergy Group PLC

TIPRANKS
·
12 Feb

Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
11 Feb

Bristol Myers Squibb Sees Positive Results for Breyanzi in Lymphoma Trials

Dow Jones
·
10 Feb

Bristol Myers announces results from Phase 2 TRANSCEND FL trial

TIPRANKS
·
10 Feb

Is Myers Industries (MYE) Among the Small–Cap Stocks Insiders Are Buying Recently?

Insider Monkey
·
08 Feb

Bristol Myers Squibb Reports Strong 2024 Financial Growth

TIPRANKS
·
07 Feb

Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
07 Feb

Bristol Myers Squibb Warns Near-Term Impact Due To Generics On 2025 Sales Forecast, Outlines $2 Billion In Additional Cost Cuts

Benzinga
·
06 Feb

Bristol Myers Wallops Fourth-Quarter Earnings Views. But Shares Plummet 5%.

Blockhead
·
06 Feb

Bristol Myers Squibb Tops Q4 Estimates

Motley Fool
·
06 Feb

Bristol Myers misses expectations for 2025 guidance, shares fall

Investing.com
·
06 Feb

Bristol Myers: Q4 Earnings Snapshot

Associated Press Finance
·
06 Feb

Bristol Myers Squibb Expects 2025 Sales Of Around $45.5B Versus Consensus Of $47.845B, And Adjusted EPS Of $6.55-$6.85 Versus $1.15 YoY

Benzinga
·
06 Feb

Bristol Myers Squibb call volume above normal and directionally bullish

TIPRANKS
·
06 Feb

Myers Industries Announces 2025 Annual Meeting Date

Business Wire
·
05 Feb

Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
04 Feb

Should Bristol Myers Stock Be in Your Portfolio Pre-Q4 Earnings?

Zacks
·
03 Feb